AR and posterior cortical atrophy: PCa, which advancesin the presence of an androgen blockade, is known as castration-resistantPCa (CRPC).4,15,16 There is much evidence that second-generation androgen receptor(AR) antagonists, such as enzalutamide (ENZ), can be used after docetaxelor abiraterone acetate treatment17 to extendthe lives of some CRPC patients.